Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -11.00x as of the fiscal period ended Sunday, December 31, 2023.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -11.00x.
INTEREST COVERAGE RATIO
-11.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
-4146.91x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+99.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.24x
median of 262 covered companies
CURRENT VS SECTOR MEDIAN
-391.02%
vs the sector median at left
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Interest Coverage Ratio
-11.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.48M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
Market Cap
$21.90M
Interest Coverage Ratio
4.39x
TTM Avg
4.39x
3Y Avg
4.39x
5Y Avg
4.39x
Market Cap
$20.93M
Interest Coverage Ratio
-1110.88x
TTM Avg
1344.27x
3Y Avg
1344.27x
5Y Avg
1344.27x
Market Cap
$18.82M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$18.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.65M
Interest Coverage Ratio
N/A
TTM Avg
1.23x
3Y Avg
1.23x
5Y Avg
1.23x
Market Cap
$30.92M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | -11.00x | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -17.20x | 55.75x | 55.75x | 55.75x |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 4.39x | 4.39x | 4.39x | 4.39x |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -1110.88x | 1344.27x | 1344.27x | 1344.27x |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -6.31x | 0.97x | 0.97x | 0.97x |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | N/A | 1.23x | 1.23x | 1.23x |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -34.63x | 34.14x | 47.81x | 52.62x |
Interest Coverage
-11.0x
Debt/Equity
0.00
Current Ratio
5.69
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -11.00x |
| 2017-06-30 | -9.83x |
| 2015-03-31 | -1840.74x |
| 2014-12-31 | -247.90x |
| 2014-09-30 | -21491.75x |
| 2014-06-30 | -2208.27x |
| 2014-03-31 | -3218.86x |
| 2013-06-30 | -7339.05x |
| 2013-03-31 | -277347.57x |
| 2012-12-31 | -7.61x |
| 2012-09-30 | -146.42x |
| 2012-06-30 | -476.62x |
| 2012-03-31 | -658.50x |
| 2011-12-31 | -122.11x |
| 2011-09-30 | -1680.99x |
| 2011-06-30 | -284.43x |
| 2011-03-31 | -45.38x |
| 2010-12-31 | -84.40x |
| 2010-09-30 | -93.06x |
